Belgium· BE-AMP-SAM347051-00
Vedrop 50 mg/ml
A tocofersolan product containing tocopherol-d-alfa, registered in Belgium by Recordati Rare Diseases. The same ATC class is registered in 11 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Tocofersolan is registered in 11 of 19 countries.
Countries holding a registration under ATC A11HA08 (tocofersolan), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 7 of them publish a price we can compare per daily dose
Tocofersolan · ATC A11HA08
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Tocopherol-D-Alfa
- Manufacturer
- Recordati Rare Diseases
- Country
- Belgium (BE)
- ATC code
- A11HA08
- ATC class
- Tocofersolan
- Defined daily dose
- 0.2 g, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under A11HA08
Tocofersolan, as other registers publish it.
- FinlandVedropRecordati Rare Diseases
- PolandVedropRecordati Rare Diseases
- NorwayVedropRecordati Rare Diseases
- IcelandVedropRecordati Rare Diseases*
- DenmarkVedropRecordati Rare Diseases
- CzechiaVEDROPRecordati Rare Diseases, Puteaux
- CzechiaVEDROPRecordati Rare Diseases, Puteaux
- CzechiaVEDROPRecordati Rare Diseases, Puteaux
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/85fd768d-9a08-47b0-92df-2d72b274c330 GET /v1/drugs/85fd768d-9a08-47b0-92df-2d72b274c330?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oral solution",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Vedrop 50 mg/ml",
"name_fr": "Vedrop 50 mg/ml",
"name_nl": "Vedrop 50 mg/ml",
"amp_code": "SAM347051-00",
"strengths": [
"50.0000",
"50.0000"
],
"pack_count": 3,
"substances": [
"Tocopherol-D-Alfa",
"Disodium Hydrogen Phosphate Dodecahydrate",
"Glycerol",
"Sodium Methyl Parahydroxybenzoate",
"Sodium Propyl Parahydroxybenzoate",
"Potassium Sorbate"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Tocofersolan",
"authorisation_numbers": [
"EU/1/09/533/001",
"EU/1/09/533/002",
"EU/1/09/533/003"
]
}See everything about tocofersolan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.